$XMAX News: XMax Inc. Announces Fiscal Year 2025 Financial

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
80
$XMAX News: XMax Inc. Announces Fiscal Year 2025 Financial Results

XMax Inc.
Wed, April 15, 2026 at 4:30 PM EDT

XMax Inc.
Company Reports 73% Revenue Growth and Strategic Expansion into Artificial Intelligence


COMMERCE, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- XMax Inc. (NASDAQ: XWIN) (formerly Nova LifeStyle, Inc.), a distributor of contemporary styled residential and commercial furniture and new player in artificial intelligence technologies, today announced financial results for the fiscal year ended December 31, 2025.

Fiscal Year 2025 Financial Highlights

Net Sales: $16.7 million, up 73% from $9.7 million in fiscal year 2024

Gross Profit: $4.2 million, representing a 25% gross margin and a decrease from gross profit of $4.25 million and gross margin of 44% for fiscal year 2024

Net Loss: $(3.4) million, improved from $(5.6) million in fiscal year 2024

Cash and Cash Equivalents: $6.7 million as of December 31, 2025, compared to $0.2 million at December 31, 2024

Working Capital: $9.9 million as of December 31, 2025, up from $2.1 million at December 31, 2024

Key Developments

Strategic Expansion into Artificial Intelligence

In March 2026, XMax's Board of Directors approved a strategic expansion into artificial intelligence (AI) while continuing to operate and develop its existing furniture business. The initiative is designed to diversify revenue streams and position the Company for long-term growth amid challenging conditions in the furniture market.

Under the new strategy, the Company plans to enter several high-growth AI segments, including:

AI software and hardware development

Cloud and GPU compute infrastructure

AI model access and orchestration

Enterprise-focused AI agent deployment

On April 2, 2026, the Company formally established a wholly owned subsidiary, XMax AI Inc. On April 6, 2026, XMax AI Inc. entered into an agreement with CLOUD ALLIANCE INC to develop and deploy a cloud-based AI inference platform to the Amazon Web Services (AWS) cloud environment designated by XMax AI. The platform is designed to support scalable AI application development, multi-model integration, and potential commercial deployment.

Management Commentary

"Fiscal year 2025 marked a transformational period for XMax," said Xiaohua Lu, Chief Executive Officer. "We achieved significant revenue growth of 73% while simultaneously strengthening our balance sheet and positioning the Company for future growth through strategic investments in high-growth technology sectors. Our expansion into artificial intelligence represents a natural evolution of our business strategy, leveraging emerging technologies to create new revenue streams while continuing to serve our core furniture customers."

"Our decision to invest in leading AI and space technology companies through carefully selected funds demonstrates our commitment to long-term value creation for shareholders," Lu continued. "As we move forward, we will continue to strengthen our core furniture operations while building scalable technology-driven business lines with significant commercial potential."

Fiscal Year 2025 Business Review

Revenue Performance

Net sales increased 73% to $16.7 million in fiscal year 2025, driven by:

102% increase in average selling prices

Three largest product categories, including marble slabs (47% of sales), sofas (30% of sales), and coffee tables (5% of sales)

Increased sales to Hong Kong representing 47.4% of total sales in 2025

Geographic Mix

North America: $8.7 million (52.1% of sales), down 8% from prior year

Hong Kong: $7.9 million (47.4% of sales), up 100% from $0 in prior year

Other Regions: $0.1 million (0.5% of sales)

Balance Sheet and Liquidity

As of December 31, 2025, XMax maintained a strong financial position with:

Total Assets: $35.5 million, up from $9.9 million at December 31, 2024

Total Liabilities: $7.6 million, up from $6.8 million at December 31, 2024

Stockholders' Equity: $28.0 million, up from $3.1 million at December 31, 2024

Current Ratio: 4.92-to-1, indicating strong short-term liquidity

Fiscal Year 2026 Outlook

Looking ahead, XMax plans to:

Continue strengthening its core furniture operations as a principal business line;

Raise and deploy capital into specific AI projects, including software and hardware development, cloud and GPU compute infrastructure, and enterprise AI agent deployment

Pursue strategic partnerships, joint ventures, or acquisitions in AI and advanced technology sectors;

Manage capital through prudent investment strategies designed to enhance overall capital efficiency and support long-term shareholder value.

About XMax Inc.

Headquartered in Commerce, California, XMax Inc. (NASDAQ: XWIN), formerly known as Nova LifeStyle, Inc., is a diversified company engaged in the design, sourcing, and distribution of contemporary furniture, as well as the development of artificial intelligence technologies and applications. The Company operates through an established global network of suppliers, distributors, and e-commerce channels, serving a broad customer base. In addition, the Company is expanding into artificial intelligence technologies, including AI software and platform-based services, to support future growth. By leveraging both its core operations and emerging technologies, the Company aims to drive diversification and long-term value creation.

Forward-Looking Statements

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, our ability to fully resume our operations and remain financially healthy, our expected future growth prospects. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. In some cases, forward-looking statements can be identified by the use of forward-looking terms such as “anticipate,” “estimate,” “believe,” “continue,” “could,” “intend,” “may,” “plan,” “potential,” “predict,” “should,” “will,” “expect,” “objective,” “projection,” “forecast,” “goal,” “guidance,” “outlook,” “effort,” “target,” “trajectory,” “focus,” “work to,” “attempt,” “pursue,” or the negative of these terms or other comparable terms. However, the absence of these words does not mean that the statements are not forward-looking. These forward-looking statements are based on certain assumptions and analyses made by us in light of our experience and our perception of historical trends, current conditions and expected future developments, as well as other factors we believe are appropriate in the circumstances.

Investor Relations Contact

ICR LLC.

XMaxIR@icrinc.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 37

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 40

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 52

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 28

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 46

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 63

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 35

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

NORBIT Secures Significant NOK 120M Defence Order

Updated Category News Views 288

NORBIT Secures Significant NOK 120 Million Defence Order NORBIT has recently made an exciting announcement regarding a significant contract within its segment PIR. The company has been awarded a manufacturing order valued at NOK 120 million from a European client specializing in defence and security. This order is poised for delivery in late 2025 and early 2026, marking a...

Continue Reading
Shareholder Concerns Over BCO, SEM, NATL Transactions

Updated Category News Views 12

Is There Smoke Without Fire in Recent Company Mergers? Well, here we go again. It seems every time deals like these pop up, questions start flying about fairness and insider scoops. The big fish here? The Brink's Company (NYSE:BCO), Select Medical Holdings Corporation (NYSE:SEM), and NCR Atleos Corporation (NYSE:NATL). Halper Sadeh LLC, the investor rights firm, is on a...

Continue Reading
TG Therapeutics Director’s Recent Stock Sale Raises Questions

Updated Category News Views 120

Significant Insider Transaction at TG Therapeutics Recently, an important transaction came to light involving Yann Echelard, Director at TG Therapeutics (NASDAQ:TGTX). The details were revealed through the latest SEC filing. On a given date, Echelard sold 5,000 shares, raising a total of $162,850. Such insider trading can often prompt discussions regarding the company’s...

Continue Reading
Innovative Leadership in Facilities Management Revolutionized

Updated Category News Views 214

MasonMade Ventures Launches to Revamp Facilities Management Serial Entrepreneurs Aim to Disrupt the FM Industry through Innovative Software Solutions and Expert Trades MasonMade Ventures, established by visionary entrepreneurs Joseph Scaretta and Moses Carrasco, is set to change the face of facilities management. This operational holding company focuses on investing in...

Continue Reading
Kyverna Therapeutics Engages Investors at Upcoming Events

Updated Category News Views 136

Kyverna Therapeutics' Upcoming Investor Conferences Kyverna Therapeutics, Inc. (NASDAQ: KYTX), a pioneering clinical-stage biopharmaceutical company committed to innovative cell therapies for autoimmune diseases, is slated to present at a series of significant investor conferences this September. Warner Biddle, the Chief Executive Officer of Kyverna, will be the...

Continue Reading